2nd Quarter - Report

RICCHETTI INCORPORATED for EISAI, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to CMS rule "Medicare Coverage of Innovative Technology (MCIT)" and definition of "reasonable and necessary"; Drug pricing and access, and Medicare and Medicaid reimbursement; Issues related to pharmaceutical industry, generally

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to CMS rule "Medicare Coverage of Innovative Technology (MCIT)" and definition of "reasonable and necessary"; Drug pricing and access, and Medicare and Medicaid reimbursement

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.